Literature DB >> 998270

C1 subcomponent conplexes in normal and pathological sera studied by crossed immunoelectrophoresis.

A B Laurell, U Mårtensson, A G Sjöholm.   

Abstract

Selected pathological sera gave three molecular species of C1s protein on crossed immunoelectrophoresis in the presence of calcium. C1s precipitates were obtained at the origin and in the beta1 and alpha2 regions. 12 normal sera gave C1s protein peaks at the origin and in alpha2 position. One of the normal sera also contained a small amount of the beta1 C1s protein. The C1s protein at the origin represented macromolecular C1. The alpha2 peak was a complex composed of C1 IA, C1s and C1r proteins. This complex was preformed in serum and did not show C4 cleaving activity. The molecular species in the beta1 region was shown to be a calcium-dependent complex of C1r and C1s, probably in proenzyme form. the C1r-C1s complex formed macromolecular C1 on addition of purified C1q to serum. During electrophoresis activation of C1 subcomponents was initiated by a mechanism involving CIr with generation of CIs activity in eluted fractions corresponding to the position of macromolecular C1 as well as in the beta region. The significance of beta1 C1s complexes or of alpha2 C1s complexes in normal and pathological sera was discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 998270     DOI: 10.1111/j.1699-0463.1976.tb00055.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand C        ISSN: 0304-1328


  12 in total

Review 1.  Biological activities of C1 inhibitor.

Authors:  Alvin E Davis; Pedro Mejia; Fengxin Lu
Journal:  Mol Immunol       Date:  2008-07-31       Impact factor: 4.407

2.  Determination of C1s-C1 inhibitor complexes in plasma by means of an enzyme linked immunosorbent assay.

Authors:  T Nilsson; O Bäck
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

Review 3.  Aspects of C1-inhibitor biochemistry and pathophysiology.

Authors:  T K Nilsson
Journal:  Clin Rheumatol       Date:  1987-09       Impact factor: 2.980

Review 4.  Methods to detect and quantitate complement activation.

Authors:  N R Cooper; G R Nemerow; J T Mayes
Journal:  Springer Semin Immunopathol       Date:  1983

5.  C1 inhibitor-dependent dissociation of human complement component C1 bound to immune complexes.

Authors:  R B Sim; G J Arlaud; M G Colomb
Journal:  Biochem J       Date:  1979-06-01       Impact factor: 3.857

6.  Analysis of the anticomplementary activity in sera of three African patients with parasitic and bacteriological infections.

Authors:  M Loos; M P Dierich
Journal:  Infect Immun       Date:  1980-01       Impact factor: 3.441

7.  The inhibition by lysine of the activation of the first component of complement, C1.

Authors:  A Takada; Y Takada
Journal:  Immunology       Date:  1982-12       Impact factor: 7.397

8.  Soluble C3 proconvertase and convertase of the classical pathway of human complement. Conditions of stabilization in vitro.

Authors:  M B Villiers; N M Thielens; M G Colomb
Journal:  Biochem J       Date:  1985-03-01       Impact factor: 3.857

Review 9.  The first component of human complement (C1): activation and control.

Authors:  R J Ziccardi
Journal:  Springer Semin Immunopathol       Date:  1983

10.  Human inhibitor of the first component of complement, C1: characterization of cDNA clones and localization of the gene to chromosome 11.

Authors:  A E Davis; A S Whitehead; R A Harrison; A Dauphinais; G A Bruns; M Cicardi; F S Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.